Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Author Correction: Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases.
Adhikary PP, Idowu T, Tan Z, Hoang C, Shanta S, Dumbani M, Mappalakayil L, Awasthi B, Bermudez M, Weiner J, Beule D, Wolber G, Page BDG, Hedtrich S. Adhikary PP, et al. Among authors: awasthi b. EMBO Mol Med. 2024 Dec;16(12):3247-3250. doi: 10.1038/s44321-024-00165-4. EMBO Mol Med. 2024. PMID: 39511312 Free PMC article.
G Protein-Coupled Estrogen Receptor-Mediated Anti-Inflammatory and Mucosal Healing Activity of a Trimethylpyridinol Analogue in Inflammatory Bowel Disease.
Awasthi BP, Chaudhary P, Lim D, Yadav K, Lee IH, Banskota S, Chaudhary CL, Karmacharya U, Lee J, Im SM, Nam Y, Eun JW, Lee S, Lee JM, Kim ES, Ryou C, Kim TH, Park HD, Kim JA, Nam TG, Jeong BS. Awasthi BP, et al. J Med Chem. 2024 Jul 11;67(13):10601-10621. doi: 10.1021/acs.jmedchem.3c02458. Epub 2024 Jun 19. J Med Chem. 2024. PMID: 38896548
Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases.
Adhikary PP, Idowu T, Tan Z, Hoang C, Shanta S, Dumbani M, Mappalakayil L, Awasthi B, Bermudez M, Weiner J, Beule D, Wolber G, Page BD, Hedtrich S. Adhikary PP, et al. Among authors: awasthi b. EMBO Mol Med. 2024 Jul;16(7):1630-1656. doi: 10.1038/s44321-024-00085-3. Epub 2024 Jun 14. EMBO Mol Med. 2024. PMID: 38877290 Free PMC article.
6-Amino-2,4,5-trimethylpyridin-3-ol and 2-amino-4,6-dimethylpyrimidin-5-ol derivatives as selective fibroblast growth factor receptor 4 inhibitors: design, synthesis, molecular docking, and anti-hepatocellular carcinoma efficacy evaluation.
Chaudhary CL, Lim D, Chaudhary P, Guragain D, Awasthi BP, Park HD, Kim JA, Jeong BS. Chaudhary CL, et al. Among authors: awasthi bp. J Enzyme Inhib Med Chem. 2022 Dec;37(1):844-856. doi: 10.1080/14756366.2022.2048378. J Enzyme Inhib Med Chem. 2022. PMID: 35296193 Free PMC article.
42 results